be_ixf;ym_201912 d_15; ct_50

Select Page

Joseph Hargett

Joseph HargettJoseph HargettEditor, Great Stuff

  • Twitter Icon
  • Facebook Icon

Joseph Hargett is the editor of Great Stuff, a daily Banyan Hill e-zine that keeps you informed on the hottest trends on Wall Street, provides you with the key information to make you filthy rich (*your results may vary) and inspires the best in dinner-table conversation. Great Stuff is finance with an edge.

Joseph joined the Banyan Hill team in 2016. Hailing from the Greater Cincinnati, Ohio, area, Joseph has spent more than a decade specializing in stock market analysis and stock and options trading strategies. Prior to joining Banyan Hill, Joseph cut his teeth in the research department of a well-respected options-based newsletter and was a regular contributor at both Forbes and InvestorPlace. He has worked as an analyst for the small-cap and biotech sectors at Cabot Heritage Corp. in Boston, Massachusetts. Joseph has been regularly quoted in a plethora of media outlets, including The Wall Street Journal, The New York Times, Money Show Digest, Reuters, USA Today, MarketWatch and Sentiment Magazine.

Joseph Hargett,
Editor, Great Stuff

Joseph's Articles

Gather ye rosebuds while ye may, it’s trade deal party time in the USA. Risk? What Risk? It’s Trade Deal Party Time!
December 13, 2019 Great Stuff
- Gather ye rosebuds while ye may, it’s trade deal party time in the USA.
Peloton Gets Pounded; Lululemon’s Discount Yoga Pants
December 12, 2019 Great Stuff
- Have I lost my mind? Or am I seriously agreeing with Andrew Left and Citron Research on Peloton Interactive?
After dropping another multibillion-dollar rescue, it’s time Wall Street and the Federal Reserve address the elephant in the room. Will Netflix Bow to Baby Yoda?
December 11, 2019 Great Stuff
- All We Are Saying Ev’rybody’s talking ’bout revolution, evolution, regulation, meditations, United Nations… But all the Federal Reserve is saying is give quantitative easing (QE) a chance. Actually, the Fed isn’t saying that … directly, anyway. (Sorry for the poor lead-in, John.) Today, Federal Reserve Chairman Jerome Powell held U.S. interest rates steady and promised […]
That December 15 deadline for new Chinese tariffs wasn’t really a deadline. It was more of a guideline. It’s time to play “kick the can” on trade again! PG&E: Let Them Eat Stocks
December 10, 2019 Great Stuff
- A Hill of Beans Of all the financial newsletters in all the towns in all the world … the “people familiar with the talks” had to walk into mine. You know how those “people” said that a trade deal would happen before the deadline for new Chinese tariffs on December 15? About that … we’re […]
We’re staring down the barrel of what could prove to be the most eventful week of the year. What’s so important this week? Central banks and trade war deals, that’s what. Tesla Stock Price Insanity; Biotech Buyout Madness
December 9, 2019 Great Stuff
- Are You Ready to Make A Deal? We’re staring down the barrel of what could prove to be the most eventful week of the year … and the market is holding its breath. (But don’t hold yours. Seriously, it’s a week. You can’t hold your breath for an entire week!) What’s so important this week? […]
After seeing the November jobs report, I have just one thing to ask you: Are you not entertained!? Tesla Is Going to $500 … or Not, Whatever
December 6, 2019 Great Stuff
- Friday Four Play: The “Look at All Those Jobs” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve profusely thanked your friend, why not sign up for the free email today? It’s mostly painless. I promise.) After […]
Biotech. All those big scary words that have no real-world meaning to investors, but the $775 billion market should pique your interest. Sometimes, It’s Lupus; Sage’s Depressing Results
December 5, 2019 Great Stuff
- The Right Prescription for Massive Returns Today, dear readers, we’re going to cover a topic I just know you all love and adore: biotechnology. I can hear the groans already … and I get it. All those big scary words that have no real meaning to you at all. It’s like they’re talking about some […]
U.S.-China trade talks are close to a deal, but Trump has yet to weigh in. Hold on to your hats, ’cause we’re going on quite a ride over the next week. Google’s New CEO; Kodiak’s Rally Is Unbearable; Tesla Stock $1
December 4, 2019 Great Stuff
- Mr. Trump’s Wild Ride Hold on to your hats, ’cause we’re going on quite a ride over the next week. Yesterday, President Trump appeared to punt the U.S.-China trade deal until after the 2020 elections. Today, however, we’re getting a different story. (And if you’re not used to this back-and-forth by now, you’re not paying […]
When it comes to the U.S.-China trade war: Fool me once, shame on you. Fool me twice … it’s peanuts. Biotech Buyouts and Peloton Fallouts
December 3, 2019 Great Stuff
- Don’t Get Fooled Again OK, dear readers. Today’s secret word is “tariffs.” When you hear the secret word, scream really loud! As if you all weren’t screaming really loud already. The Dow is down more than 400 points, and all the major market indexes have shed roughly 1% or more. And why are we mired […]
Turkey, trade and tariffs tank the market rally. All Hail the American Consumer: Largest Black Friday…Ever.
December 2, 2019 Great Stuff
- Manufacturing a Crisis After logging their biggest monthly gains since June, the markets showed a bit of fatigue today. Maybe it’s tired traders returning from the long holiday weekend. Maybe it was all the turkey. I know I’m still feeling overstuffed after the Thanksgiving break. It would be nice if these were today’s main market […]

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

I am up $20,070 in closed positions from Feb. 18 through March 7.

- Bob Rowe

I started your system in December … I am ahead $29,000 … I put total faith in you and your system and it has worked for me very nicely. Thanks again I sure like your humble approach about this whole thing

- Dale Leiffer

I have made a little over $4,000 while being cautious.

- Chuck Goss